Stocks AVO Financial statements
Financial statementsMission Produce, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Mission Produce, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 883 | 862 | 892 | 1,046 | 954 | 1,235 | 1,391 |
| Cost of revenue | 729 | 738 | 767 | 956 | 871 | 1,082 | 1,231 |
| Gross profit | 155 | 125 | 125 | 89.8 | 83.3 | 153 | 161 |
| Selling, general and administrative | 48.2 | 56.2 | 63.6 | 77.5 | 76.4 | 86.8 | 95.5 |
| Operating income | 107 | 68.4 | 60.9 | -37.2 | 6.9 | 65.7 | 65.2 |
| Interest expense | 10.3 | 6.7 | 3.7 | 5.5 | 11.6 | 12.6 | 9.4 |
| Interest income | 1.7 | 2.4 | 1.7 | 1.7 | 1.5 | 2.1 | 1.7 |
| Other non-operating income | -3.6 | -0.7 | 1.3 | 4.4 | -0.2 | 3.6 | 0.7 |
| Pre-tax income | 96 | 43.8 | 66 | -31.2 | -0.9 | 60.4 | 61.9 |
| Income tax | 24.3 | 15 | 21.1 | 3.7 | 2.2 | 18.6 | 21.4 |
| Net income to minority interests | 0 | 0 | -0.3 | -0.3 | 5.1 | 2.8 | |
| Net income | 71.7 | 28.8 | 44.9 | -34.6 | -2.8 | 36.7 | 37.7 |
| EBITDA | 123 | 86.5 | 81.3 | -12.4 | 39.7 | 103 | 99.8 |
| EPS, basic | 1.13 | 0.45 | 0.64 | -0.49 | -0.04 | 0.52 | 0.53 |
| EPS, diluted | 1.13 | 0.45 | 0.63 | -0.49 | -0.04 | 0.52 | 0.53 |
| Shares, basic (weighted) | 63.4 | 63.6 | 70.6 | 70.6 | 70.8 | 70.9 | 70.8 |
| Shares, diluted (weighted) | 63.5 | 63.7 | 71.1 | 70.6 | 70.8 | 71 | 71.3 |
| Dividend per share | 0.09 | 0.21 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 64 | 124 | 84.5 | 52.8 | 42.9 | 58 | 64.8 |
| Inventory | 38.6 | 48.2 | 73.1 | 70.8 | 91.2 | 80.6 | |
| Other current assets | 8.8 | 11.6 | 11.1 | 9.1 | 9.4 | 8.5 | |
| Total current assets | 248 | 247 | 228 | 220 | 279 | 262 | |
| Property, plant and equipment | 379 | 424 | 490 | 523 | 523 | 542 | |
| Lease right-of-use assets | 0 | 43.9 | 65.4 | 72.4 | 67.8 | 67.7 | |
| Goodwill | 76.4 | 76.4 | 39.4 | 39.4 | 39.4 | 39.4 | |
| Intangible assets | 0 | 2 | 0.5 | 0 | 0 | ||
| Other non-current assets | 18.1 | 19.8 | 19.7 | 19.7 | 19.2 | 26.5 | |
| Total assets | 777 | 874 | 880 | 915 | 972 | 983 | |
| Accounts payable | 20.5 | 22.8 | 34.4 | 27.2 | 35.3 | 47.3 | |
| Accrued liabilities | 28.3 | 28.8 | 30.1 | 26.4 | 39.9 | 38.9 | |
| Deferred revenue | 0 | ||||||
| Short-term debt | 7.4 | 8.8 | 3.5 | 3.4 | 3 | 3 | |
| Total current liabilities | 77.9 | 89.2 | 102 | 97.5 | 149 | 135 | |
| Long-term debt | 167 | 155 | 137 | 149 | 111 | 92.8 | |
| Lease liabilities | 0 | 42.5 | 63.9 | 71 | 67.4 | 67.5 | |
| Other non-current liabilities | 24.3 | 20 | 19.2 | 26.4 | 26 | 26.3 | |
| Total liabilities | 304 | 339 | 357 | 387 | 394 | 363 | |
| Total debt | 174 | 164 | 140 | 152 | 114 | 95.8 | |
| Paid-in capital | 223 | 226 | 229 | 233 | 240 | 247 | |
| Retained earnings | 251 | 309 | 274 | 271 | 308 | 339 | |
| Other comprehensive income | -0.5 | -0.5 | -1.7 | -0.9 | -0.2 | 0.6 | |
| Shareholders' equity | 379 | 474 | 534 | 502 | 504 | 547 | 587 |
| Minority interests | 0 | 20.8 | 24.7 | 29.8 | 32.6 | ||
| Total equity | 379 | 474 | 534 | 523 | 528 | 577 | 620 |
| Total liabilities and equity | 777 | 874 | 880 | 915 | 972 | 983 | |
| Shares outstanding | 70.6 | 70.6 | 70.7 | 70.7 | 70.9 | 70.6 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 71.7 | 28.8 | 44.9 | -34.9 | -3.1 | 41.8 | 40.5 |
| Depreciation and amortization | 16.5 | 18.1 | 20.4 | 24.8 | 32.8 | 37.7 | 34.6 |
| Stock-based compensation | 0 | 5 | 2.6 | 3.6 | 4.5 | 7.1 | 8.8 |
| Deferred income tax | 0.6 | -1 | 8.8 | -0.6 | -6.4 | -8 | 1.9 |
| Change in inventory | -12.3 | 5.9 | -11.2 | -15.3 | 3 | -19.3 | 11.1 |
| Change in payables | 5.2 | 8.2 | 8.9 | 9.4 | -8.9 | 25.4 | 12.3 |
| Cash from operations | 92.6 | 78.9 | 47 | 35.2 | 29.2 | 93.4 | 88.6 |
| Capital expenditures | -29.7 | -67.3 | -73.4 | -61.2 | -49.8 | -32.2 | -51.4 |
| Cash from investing | -30.7 | -67.7 | -70.3 | -51.4 | -54.1 | -33.5 | -51.9 |
| Debt repaid | -14.2 | -6.3 | -10.5 | -63.3 | -3.5 | -3.4 | -3 |
| Stock issued | 0 | 78.1 | 0 | 0 | 0.1 | 0 | 0.3 |
| Share buybacks | -0.9 | -1.9 | 0 | 0 | -0.6 | 0 | -6.1 |
| Dividends paid | -5.6 | -13 | 0 | 0 | |||
| Cash from financing | -26.8 | 50.1 | -11.5 | -21.8 | 14.3 | -43.8 | -29.5 |
| Exchange rate effect | 0 | 0.1 | 0 | -0.3 | -0.1 | 0 | 0 |
| Net change in cash | 35.1 | 61.4 | -34.8 | -38.3 | -10.7 | 16.1 | 7.2 |
| Free cash flow | 62.9 | 11.6 | -26.4 | -26 | -20.6 | 61.2 | 37.2 |
| Interest paid | 10.5 | 6.3 | 4.3 | 5.7 | 11.5 | 12.2 | 9.1 |
| Income taxes paid | 21.5 | 18.5 | 14.8 | 6.2 | 7.1 | 19.6 | 23 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 11.4% | Gross profit / revenue. |
| Operating margin | 1.8% | Operating income / revenue. |
| EBITDA margin | 4.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 1.1% | Pre-tax income / revenue. |
| Net margin | 0.1% | Net income / revenue. |
| FCF margin | -0.2% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 3.1% | Cash from operations / revenue. |
| Effective tax rate | 76.8% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 0.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.1% | Net income / average total assets. |
| Return on invested capital (ROIC) | 1.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 8.2% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 3.3% | Capital expenditures / revenue. |
| D&A / revenue | 3.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 12.7% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 10.0% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 10.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 5.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 21.4% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 5.2% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -0.8% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 5y | -1.0% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -3.5% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 5y | 2.9% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 2.7% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 5y | 5.5% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 1.9% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 5y | 3.3% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -5.1% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 36.0% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 2.3% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -39.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | 26.2% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 7.3% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 5.4% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 4.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 1.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 3.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 4.8% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 2.3% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.92x | Current assets / current liabilities. |
| Quick ratio | 0.22x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.22x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.52x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 24.9% | Total debt / total assets. |
| Liabilities / assets | 50.2% | Total liabilities / total assets. |
| Net debt | $353.2M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 5.41x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 2.18x | Operating income / interest expense. |
| Working capital | $192.2M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 23.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $395.0M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.83x | Revenue / average total assets. |
| Fixed asset turnover | 2.04x | Revenue / average property, plant and equipment. |
| Inventory turnover | 8.39x | Cost of revenue / average inventory. |
| Days inventory | 43 days | 365 x average inventory / cost of revenue. |
| Days payables | 19 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | -143.8% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 105.6% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.02 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $16.16 | Revenue / diluted weighted shares. |
| FCF per share | -$0.03 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.50 | Cash from operations / diluted weighted shares. |
| Book value per share | $8.71 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $4.51 | Tangible book value / shares outstanding. |
| Cash per share | $0.54 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.16B | Share price x shares outstanding. |
| Enterprise value | $1.51B | Market cap + total debt - cash - short-term investments. |
| P/E | 725x | Market cap / net income. Only when net income is positive. |
| P/S | 0.87x | Market cap / revenue. |
| P/B | 1.52x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 2.94x | Market cap / tangible book value, when positive. |
| P/OCF | 28.1x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.13x | Enterprise value / revenue. |
| EV/EBIT | 63.1x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 23.2x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -0.2% | Free cash flow / market cap. |
| Earnings yield | 0.1% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 0.9% | (Dividends paid + share buybacks) / market cap. |
What was Mission Produce, Inc.'s revenue in fiscal 2025?
Mission Produce, Inc. reported revenue of $1.39B for fiscal 2025, 12.7% higher than the year before.
Was Mission Produce, Inc. profitable in fiscal 2025?
Yes. Net income was $37.7M, a net margin of 2.7%.
How much free cash flow did Mission Produce, Inc. generate in fiscal 2025?
Cash from operations of $88.6M minus capital expenditures of $51.4M left free cash flow of $37.2M.